A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant

Summary

The purpose of this study is to determine if Eculizumab is safe and effective in the prevention of delayed graft function following deceased donor kidney transplantation.

Timeline

Start

2011-12-01

Primary completion

2013-08-06

Completion

2014-02-06

Outcome

Outcome not reported

Stopped: “After interim analysis, the pilot study was terminated and modified to a larger multicenter study (NCT01919346) to better assess efficacy.”

Drugs

Indications